Viking Therapeutics Inc (VKTX) - News Archive

Viking Therapeutics, a clinical-stage biopharmaceutical company specializing in metabolic and endocrine disorder therapies, has recently announced the successful closing of its public offering of common stock. With an o...

Viking Therapeutics Makes Major Move with $550 Million Public OfferingViking Therapeutics, Inc. has made a significant announcement with the pricing of its $550 million public offering of common stock. This clinical-sta...